“…They can be related to immunosuppressive conditioning therapy ( e.g ., busulfan, cyclophosphamide, gemtuzumab ozogamicin, inotuzumab ozogamicin and total body irradiation), to the transplantation itself such as graft versus host disease (GVHD) 2 or sinusoidal obstruction syndrome (SOS), 3 to drug‐induced liver injury (DILI) after transplantation ( e.g ., antifungals) 4 . Sepsis‐associated liver injury (SALI) is also frequent and multifactorial 5 . Less often, relapse of haematological disease, cholelithiasis, viral reactivation (hepatitis B virus and cytomegalovirus), hepatitis E, 6 ischaemic hepatitis, iron overload (secondary in part to transfusions) 7 and metabolic dysfunction‐associated steatotic liver disease can also be the culprit 8 .…”